scholarly article | Q13442814 |
P356 | DOI | 10.1097/00002371-200103000-00014 |
P698 | PubMed publication ID | 11265777 |
P50 | author | Steven Rosenberg | Q2347448 |
P2093 | author name string | Witebsky FG | |
Steinberg SM | |||
Marincola FM | |||
Mavroukakis SA | |||
Goodwin RS | |||
McIntyre LS | |||
Seipp CA | |||
Ohnmacht GA | |||
Morton KE | |||
Phan GQ | |||
Muehlbauer PM | |||
Shea YR | |||
Rogers-Freezer LJ | |||
P433 | issue | 2 | |
P921 | main subject | placebo-controlled trial | Q108853737 |
nystatin | Q251005 | ||
placebo | Q269829 | ||
P304 | page(s) | 188-192 | |
P577 | publication date | 2001-03-01 | |
P1433 | published in | Journal of Immunotherapy | Q15763946 |
P1476 | title | A prospective, randomized, double-blind, placebo-controlled trial evaluating the effect of nystatin on the development of oral irritation in patients receiving high-dose intravenous interleukin-2 | |
P478 | volume | 24 |
Q24244555 | Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients |
Q24187300 | Immunotherapy for advanced renal cell cancer |
Q24246777 | Immunotherapy for advanced renal cell cancer |
Q24243046 | Interventions for preventing oral mucositis for patients with cancer receiving treatment |
Q24246310 | Interventions for preventing oral mucositis for patients with cancer receiving treatment |
Search more.